Expressiona and Diagnostic Potential of miRNAs in NSCLC

Al-Azhar University100 enrolled

Overview

Its to explore the expression pattern, diagnostic and prognostic potentials of miRs (106b-5p, 601 and 760) in serum of NSCLC patients

A retrospective observational study on NSCLC patients, to determine the serum expression levels if some miRNAs in NSCLC patients and to find if having proper diagnostic and prognostic values in early disease detection, and/or staging.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Non Small Cell Lung Cancer

Interventions

No interventionOTHER

No intervention

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * First time and recently diagnosed NSCLC patient Exclusion Criteria: * Recurrent NSCLC * Start of chemotherapy, radiotherapy or surgical intervention * Previous treatment * Cancer history

Locations (1)

Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt

Cairo, Egypt

Outcomes

Primary Outcomes

Determination of the expression

Expression profiling of the selected miRNAs

Time frame: By the end of the study (September 2022)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.